Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Atea Pharmaceuticals, Inc. (AVIR)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
31 Jan 2024
Hammond Janet MJ
Chief Development Officer, Officer
Atea Pharmaceuticals, Inc.
(AVIR)
35,362
-28%
14,029
$3.84
$53,913.45
SELL
31 Jan 2024
Foster Wayne
EVP, Chief Accounting Officer, Officer
Atea Pharmaceuticals, Inc.
(AVIR)
20,857
-37%
12,477
$3.84
$47,904.20
SELL
31 Jan 2024
Vavricka John
Chief Commercial Officer, Officer
Atea Pharmaceuticals, Inc.
(AVIR)
21,515
-35%
11,819
$3.84
$45,420.42
SELL
31 Jan 2024
Horga Maria Arantxa
Chief Medical Officer, Officer
Atea Pharmaceuticals, Inc.
(AVIR)
25,664
-38%
15,870
$3.84
$60,963.02
SELL
31 Jan 2024
Corcoran Andrea
See Remarks, Officer
Atea Pharmaceuticals, Inc.
(AVIR)
670,208
-2%
15,843
$3.84
$60,914.75
SELL
31 Jan 2024
Sommadossi Jean-Pierre
President, CEO, and Chairman, Director, Officer
Atea Pharmaceuticals, Inc.
(AVIR)
116,557
-32%
56,910
$3.85
$218,818.95
SELL
11 Nov 2022
BERGER FRANKLIN M
Director
Atea Pharmaceuticals, Inc.
(AVIR)
778,353
-5%
41,666
$5.15
$214,684.56
BUY
20 Dec 2021
Murphy Polly A.
Director
Atea Pharmaceuticals, Inc.
(AVIR)
23,295
+106%
12,000
$8.57
$102,795.60
BUY
3 Nov 2020
Rock Springs Capital Management LP
10% Owner
Atea Pharmaceuticals, Inc.
(AVIR)
1,654,724
+17%
250,000
$24.00
$6,000,000.00
BUY
3 Nov 2020
BERGER FRANKLIN M
Director
Atea Pharmaceuticals, Inc.
(AVIR)
820,019
+5%
41,666
$24.00
$999,984.00
BUY
3 Nov 2020
Hack Andrew A. F.
Director
Atea Pharmaceuticals, Inc.
(AVIR)
5,615,659
+4%
250,000
$24.00
$6,000,000.00
Home